Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry: Rapid identification of bacteria isolated from patients with cystic fibrosis

British Journal of Biomedical Science

Volumn 70, Issue 4, 2013, Pages 144-148

  Baillie, S ^a   Ireland, K ^a   Warwick, S ^b   Wareham, D ^a,b   Wilks, M ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

Cystic fibrosis; Microbiology; Spectrometry, mass, matrix assisted laser desorption ionization

Indexed keywords

ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOCHEMISTRY; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SPUTUM; STENOTROPHOMONAS MALTOPHILIA; CLASSIFICATION; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METHODOLOGY; MICROBIOLOGY; PHENOTYPE; PREDICTIVE VALUE; PSEUDOMONAS INFECTION; REPRODUCIBILITY; TIME;

BACTERIAL TYPING TECHNIQUES; CYSTIC FIBROSIS; HUMANS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REPRODUCIBILITY OF RESULTS; RESPIRATORY TRACT INFECTIONS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPUTUM; TIME FACTORS;

EID: 84893196868     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2013.11669948     Document Type: Article

References (25)

1. Cystic Fibrosis Foundation. Lung Function. Patient Registry Annual Data Report, 2008.
2. Lipuma J. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010; 23 (2): 299-323.
3. Brigitte F, Hart N, Belfar S et al. Burkholderia cepacia is associated with pulmonary hypertension and increased mortality among cystic fibrosis patients. J Clin Microbiol 2004; 42 (12): 5537-41. (Pubitemid 39664333)
4. Salunkhe P, Smart CH, Morgan J et al. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J Bacteriol 2005; 187 (14): 4908-20. (Pubitemid 40962208)
5. Cystic Fibrosis Trust Microbiology Laboratory Standards Working Group. Laboratory Standards for Processing Microbiological Samples from Patients with Cystic Fibrosis. Cystic Fibrosis Trust, 2010.
6. de Vrankrijker AM, Wolfs TF, van der Ent CK. Challenging and emerging pathogens in cystic fibrosis. Paediatr Respir Rev 2010; 11 (4): 246-54.
7. Song KP, Chan TK, Ji ZL, Wong SW. Rapid identification of Pseudomonas aeruginosa from ocular isolates by PCR using exotoxin A-specific primers. Mol Cell Probes 2000; 14 (4):199-204.
8. Qin X, Emerson J, Stapp J, Stapp L, Abe P, Burns JL. Use of realtime PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting Gram-negative bacilli from patients with cystic fibrosis. J Clin Microbiol 2003; 41 (9):4312-7. (Pubitemid 37099701)
9. Hsieh SY, Tseng CL, Lee YS et al. Highly efficient classification and identification of human pathogenic bacteria by MALDITOF MS. Mol Cell Proteomics 2008; 7 (2): 448-56.
10. Seng P, Drancourt M, Gouriet F et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time of flight mass spectrometry. Clin Infect Dis 2009; 49 (4): 543-51.
11. Stevenson LG, Drake SK, Murray PR. Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2010; 48 (2): 444-7.
12. Degand N, Carbonnelle E, Dauphin B et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting Gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol 2008; 46 (10): 3361-7.
13. Miñán A, Alejandra B, Lasch P et al. Rapid identification of Burkholderia cepacia complex species including strains of the novel Taxon K, recovered from cystic fibrosis patients by intact cell MALDI-ToF mass spectrometry. Analyst 2009; 134 (6): 1138-48.
14. Hogardt M, Ulrich J, RiehnKopp H, Burkhard T. EuroCareCF quality assessment of diagnostic microbiology of cystic fibrosis isolates. J Clin Microbiol 2009; 47 (11): 3435-8.
15. Ratjen F, Munck A, Kho P, Angyalosi G; ELITE Study Group. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax 2010; 65 (4): 286-91.
16. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002; 34 (2): 91-100. (Pubitemid 34809519)
17. Cystic Fibrosis Trust. The Burkholderia cepacia complex: suggestions for prevention and infection control 2nd edn. Bromley, Kent: CFT, 2004.
18. Fernández-Olmos A, García-Castillo M, Morosini MI, Lamas A, Máiz L, Cantón R. MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients. J Cyst Fibros 2012; 11 (1): 59-62.
19. Courtney J, Dunbar K, McDowell A et al. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults. J Cyst Fibros 2004; 3 (2): 93-8. (Pubitemid 38987020)
20. Foweraker J. Recent advances in the microbiology of respiratory tract infection in cystic fibrosis. Br Med Bull 2009; 89: 93-110.
21. Dekimpe V, Deziel E. Revisiting the quorum-sensing hierarchy in Pseudomonas aeruginosa: the transcriptional regulator RhlR regulates LasR-specific factors. Microbiology 2009; 155 (Pt 3): 712-23.
22. Murray T, Egan M, Kazmierczak B. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Curr Opin Pediatr 2007; 19 (1): 83-8. (Pubitemid 46114762)
23. van Veen SQ, Class EC, Kupjer EJ. High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization mass spectrometry (MALDI-TOF MS) in routine medical microbiology laboratory. J Clin Microbiol 2010; 48 (3): 900-7.
24. Valerius NH, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991; 338 (8769): 725-6.
25. Xu J, Moore JE, Murphy PG, Millar BC, Elborn JS. Early detection of Pseudomonas aeruginosa - comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF). Ann Clin Microbiol Antimicrob 2004; 3: 21.